ICD-10 · PDGM grouping
E70-E88 — Metabolic disorders
Every ICD-10-CM code in this range and the PDGM clinical group CMS assigns to it, read from the CMS grouper crosswalk v07.1.26.
OASIS-E2 v1.00.0 · ingested 2026-04-26
Codes in range
286
No clinical group
7
A period cannot be grouped from these.
Barred as primary
1
CMS rejects these in the primary position.
Where these codes group
262 of the 286 codes in E70-E88 group to MMTA - Other, but the range is not uniform — it spreads across 4 clinical groups. A further 7 are assigned no clinical group at all, which means a 30-day period cannot be grouped from them.
Every code in E70-E88
Descriptions are CMS’s own, abbreviated as CMS abbreviates them.
| Code | Description | Clinical group | Primary position |
|---|---|---|---|
| E700 | Classical phenylketonuria | A | Accepted |
| E701 | Other hyperphenylalaninemias | A | Accepted |
| E7020 | Disorder of tyrosine metabolism, unspecified | A | Accepted |
| E7021 | Tyrosinemia | A | Accepted |
| E7029 | Other disorders of tyrosine metabolism | A | Accepted |
| E7030 | Albinism, unspecified | A | Accepted |
| E70310 | X-linked ocular albinism | A | Accepted |
| E70311 | Autosomal recessive ocular albinism | A | Accepted |
| E70318 | Other ocular albinism | A | Accepted |
| E70319 | Ocular albinism, unspecified | A | Accepted |
| E70320 | Tyrosinase negative oculocutaneous albinism | A | Accepted |
| E70321 | Tyrosinase positive oculocutaneous albinism | A | Accepted |
| E70328 | Other oculocutaneous albinism | A | Accepted |
| E70329 | Oculocutaneous albinism, unspecified | A | Accepted |
| E70330 | Chediak-Higashi syndrome | A | Accepted |
| E70331 | Hermansky-Pudlak syndrome | A | Accepted |
| E70338 | Other albinism with hematologic abnormality | A | Accepted |
| E70339 | Albinism with hematologic abnormality, unspecified | A | Accepted |
| E7039 | Other specified albinism | A | Accepted |
| E7040 | Disorders of histidine metabolism, unspecified | A | Accepted |
| E7041 | Histidinemia | A | Accepted |
| E7049 | Other disorders of histidine metabolism | A | Accepted |
| E705 | Disorders of tryptophan metabolism | A | Accepted |
| E7081 | Aromatic L-amino acid decarboxylase deficiency | A | Accepted |
| E7089 | Other disorders of aromatic amino-acid metabolism | A | Accepted |
| E709 | Disorder of aromatic amino-acid metabolism, unspecified | A | Accepted |
| E710 | Maple-syrup-urine disease | A | Accepted |
| E71110 | Isovaleric acidemia | A | Accepted |
| E71111 | 3-methylglutaconic aciduria | A | Accepted |
| E71118 | Other branched-chain organic acidurias | A | Accepted |
| E71120 | Methylmalonic acidemia | A | Accepted |
| E71121 | Propionic acidemia | A | Accepted |
| E71128 | Other disorders of propionate metabolism | A | Accepted |
| E7119 | Other disorders of branched-chain amino-acid metabolism | A | Accepted |
| E712 | Disorder of branched-chain amino-acid metabolism, unsp | A | Accepted |
| E7130 | Disorder of fatty-acid metabolism, unspecified | A | Accepted |
| E71310 | Long chain/very long chain acyl CoA dehydrogenase deficiency | A | Accepted |
| E71311 | Medium chain acyl CoA dehydrogenase deficiency | A | Accepted |
| E71312 | Short chain acyl CoA dehydrogenase deficiency | A | Accepted |
| E71313 | Glutaric aciduria type II | A | Accepted |
| E71314 | Muscle carnitine palmitoyltransferase deficiency | A | Accepted |
| E71318 | Other disorders of fatty-acid oxidation | A | Accepted |
| E7132 | Disorders of ketone metabolism | A | Accepted |
| E7139 | Other disorders of fatty-acid metabolism | A | Accepted |
| E7140 | Disorder of carnitine metabolism, unspecified | A | Accepted |
| E7141 | Primary carnitine deficiency | A | Accepted |
| E7142 | Carnitine deficiency due to inborn errors of metabolism | A | Accepted |
| E7143 | Iatrogenic carnitine deficiency | A | Accepted |
| E71440 | Ruvalcaba-Myhre-Smith syndrome | A | Accepted |
| E71448 | Other secondary carnitine deficiency | A | Accepted |
| E7150 | Peroxisomal disorder, unspecified | A | Accepted |
| E71510 | Zellweger syndrome | A | Accepted |
| E71511 | Neonatal adrenoleukodystrophy | A | Accepted |
| E71518 | Other disorders of peroxisome biogenesis | A | Accepted |
| E71520 | Childhood cerebral X-linked adrenoleukodystrophy | A | Accepted |
| E71521 | Adolescent X-linked adrenoleukodystrophy | A | Accepted |
| E71522 | Adrenomyeloneuropathy | A | Accepted |
| E71528 | Other X-linked adrenoleukodystrophy | A | Accepted |
| E71529 | X-linked adrenoleukodystrophy, unspecified type | A | Accepted |
| E7153 | Other group 2 peroxisomal disorders | A | Accepted |
| E71540 | Rhizomelic chondrodysplasia punctata | A | Accepted |
| E71541 | Zellweger-like syndrome | A | Accepted |
| E71542 | Other group 3 peroxisomal disorders | A | Accepted |
| E71548 | Other peroxisomal disorders | A | Accepted |
| E7200 | Disorders of amino-acid transport, unspecified | A | Accepted |
| E7201 | Cystinuria | A | Accepted |
| E7202 | Hartnup's disease | A | Accepted |
| E7203 | Lowe's syndrome | A | Accepted |
| E7204 | Cystinosis | A | Accepted |
| E7209 | Other disorders of amino-acid transport | A | Accepted |
| E7210 | Disorders of sulfur-bearing amino-acid metabolism, unsp | A | Accepted |
| E7211 | Homocystinuria | A | Accepted |
| E7212 | Methylenetetrahydrofolate reductase deficiency | A | Accepted |
| E7219 | Other disorders of sulfur-bearing amino-acid metabolism | A | Accepted |
| E7220 | Disorder of urea cycle metabolism, unspecified | A | Accepted |
| E7221 | Argininemia | A | Accepted |
| E7222 | Arginosuccinic aciduria | A | Accepted |
| E7223 | Citrullinemia | A | Accepted |
| E7229 | Other disorders of urea cycle metabolism | A | Accepted |
| E723 | Disorders of lysine and hydroxylysine metabolism | A | Accepted |
| E724 | Disorders of ornithine metabolism | A | Accepted |
| E7250 | Disorder of glycine metabolism, unspecified | A | Accepted |
| E7251 | Non-ketotic hyperglycinemia | A | Accepted |
| E7252 | Trimethylaminuria | A | Accepted |
| E72530 | Primary hyperoxaluria, type 1 | A | Accepted |
| E72538 | Other specified primary hyperoxaluria | A | Accepted |
| E72539 | Primary hyperoxaluria, unspecified | A | Accepted |
| E72540 | Dietary hyperoxaluria | A | Accepted |
| E72541 | Enteric hyperoxaluria | A | Accepted |
| E72548 | Other secondary hyperoxaluria | A | Accepted |
| E72549 | Secondary hyperoxaluria, unspecified | A | Accepted |
| E7259 | Other disorders of glycine metabolism | A | Accepted |
| E7281 | Disorders of gamma aminobutyric acid metabolism | I | Accepted |
| E7289 | Other specified disorders of amino-acid metabolism | I | Accepted |
| E729 | Disorder of amino-acid metabolism, unspecified | None | Cannot group |
| E730 | Congenital lactase deficiency | A | Accepted |
| E731 | Secondary lactase deficiency | A | Accepted |
| E738 | Other lactose intolerance | A | Accepted |
| E739 | Lactose intolerance, unspecified | A | Accepted |
| E7400 | Glycogen storage disease, unspecified | A | Accepted |
| E7401 | von Gierke disease | A | Accepted |
| E7402 | Pompe disease | A | Accepted |
| E7403 | Cori disease | A | Accepted |
| E7404 | McArdle disease | A | Accepted |
| E7405 | Lysosome-associated membrane protein 2 [LAMP2] deficiency | A | Accepted |
| E7409 | Other glycogen storage disease | A | Accepted |
| E7410 | Disorder of fructose metabolism, unspecified | A | Accepted |
| E7411 | Essential fructosuria | A | Accepted |
| E7412 | Hereditary fructose intolerance | A | Accepted |
| E7419 | Other disorders of fructose metabolism | A | Accepted |
| E7420 | Disorders of galactose metabolism, unspecified | A | Accepted |
| E7421 | Galactosemia | A | Accepted |
| E7429 | Other disorders of galactose metabolism | A | Accepted |
| E7431 | Sucrase-isomaltase deficiency | A | Accepted |
| E7439 | Other disorders of intestinal carbohydrate absorption | A | Accepted |
| E744 | Disorders of pyruvate metabolism and gluconeogenesis | A | Accepted |
| E74810 | Glucose transporter protein type 1 deficiency | A | Accepted |
| E74818 | Other disorders of glucose transport | A | Accepted |
| E74819 | Disorders of glucose transport, unspecified | A | Accepted |
| E74820 | SLC13A5 Citrate Transporter Disorder | A | Accepted |
| E74829 | Other disorders of citrate metabolism | A | Accepted |
| E7489 | Other specified disorders of carbohydrate metabolism | A | Accepted |
| E749 | Disorder of carbohydrate metabolism, unspecified | None | Cannot group |
| E7500 | GM2 gangliosidosis, unspecified | A | Accepted |
| E7501 | Sandhoff disease | A | Accepted |
| E7502 | Tay-Sachs disease | A | Accepted |
| E7509 | Other GM2 gangliosidosis | A | Accepted |
| E7510 | Unspecified gangliosidosis | A | Accepted |
| E7511 | Mucolipidosis IV | A | Accepted |
| E7519 | Other gangliosidosis | A | Accepted |
| E7521 | Fabry (-Anderson) disease | A | Accepted |
| E7522 | Gaucher disease | A | Accepted |
| E7523 | Krabbe disease | A | Accepted |
| E75240 | Niemann-Pick disease type A | A | Accepted |
| E75241 | Niemann-Pick disease type B | A | Accepted |
| E75242 | Niemann-Pick disease type C | A | Accepted |
| E75243 | Niemann-Pick disease type D | A | Accepted |
| E75244 | Niemann-Pick disease type A/B | K | Accepted |
| E75248 | Other Niemann-Pick disease | A | Accepted |
| E75249 | Niemann-Pick disease, unspecified | A | Accepted |
| E7525 | Metachromatic leukodystrophy | A | Accepted |
| E7526 | Sulfatase deficiency | B | Accepted |
| E7527 | Pelizaeus-Merzbacher disease | A | Accepted |
| E7528 | Canavan disease | A | Accepted |
| E7529 | Other sphingolipidosis | A | Accepted |
| E753 | Sphingolipidosis, unspecified | A | Accepted |
| E754 | Neuronal ceroid lipofuscinosis | A | Accepted |
| E755 | Other lipid storage disorders | A | Accepted |
| E756 | Lipid storage disorder, unspecified | A | Accepted |
| E7601 | Hurler's syndrome | A | Accepted |
| E7602 | Hurler-Scheie syndrome | A | Accepted |
| E7603 | Scheie's syndrome | A | Accepted |
| E761 | Mucopolysaccharidosis, type II | A | Accepted |
| E76210 | Morquio A mucopolysaccharidoses | A | Accepted |
| E76211 | Morquio B mucopolysaccharidoses | A | Accepted |
| E76219 | Morquio mucopolysaccharidoses, unspecified | A | Accepted |
| E7622 | Sanfilippo mucopolysaccharidoses | A | Accepted |
| E7629 | Other mucopolysaccharidoses | A | Accepted |
| E763 | Mucopolysaccharidosis, unspecified | A | Accepted |
| E768 | Other disorders of glucosaminoglycan metabolism | A | Accepted |
| E769 | Glucosaminoglycan metabolism disorder, unspecified | A | Accepted |
| E770 | Defects in post-translational mod of lysosomal enzymes | A | Accepted |
| E771 | Defects in glycoprotein degradation | A | Accepted |
| E778 | Other disorders of glycoprotein metabolism | A | Accepted |
| E779 | Disorder of glycoprotein metabolism, unspecified | A | Accepted |
| E7800 | Pure hypercholesterolemia, unspecified | A | Accepted |
| E78010 | Homozygous familial hypercholesterolemia [HoFH] | A | Accepted |
| E78011 | Heterozygous familial hypercholesterolemia [HeFH] | A | Accepted |
| E78019 | Familial hypercholesterolemia, unspecified | A | Accepted |
| E781 | Pure hyperglyceridemia | A | Accepted |
| E782 | Mixed hyperlipidemia | A | Accepted |
| E783 | Hyperchylomicronemia | A | Accepted |
| E7841 | Elevated Lipoprotein(a) | A | Accepted |
| E7849 | Other hyperlipidemia | A | Accepted |
| E785 | Hyperlipidemia, unspecified | A | Accepted |
| E786 | Lipoprotein deficiency | A | Accepted |
| E7870 | Disorder of bile acid and cholesterol metabolism, unsp | A | Accepted |
| E7871 | Barth syndrome | A | Accepted |
| E7872 | Smith-Lemli-Opitz syndrome | A | Accepted |
| E7879 | Other disorders of bile acid and cholesterol metabolism | A | Accepted |
| E7881 | Lipoid dermatoarthritis | A | Accepted |
| E7889 | Other lipoprotein metabolism disorders | A | Accepted |
| E789 | Disorder of lipoprotein metabolism, unspecified | None | Cannot group |
| E790 | Hyperuricemia w/o signs of inflam arthrit and tophaceous dis | A | Accepted |
| E791 | Lesch-Nyhan syndrome | A | Accepted |
| E792 | Myoadenylate deaminase deficiency | A | Accepted |
| E7981 | Aicardi-Goutieres syndrome | A | Accepted |
| E7982 | Hereditary xanthinuria | A | Accepted |
| E7989 | Oth disrd of purine and pyrimidine metabolism | None | Cannot group |
| E799 | Disorder of purine and pyrimidine metabolism, unspecified | A | Accepted |
| E800 | Hereditary erythropoietic porphyria | A | Accepted |
| E801 | Porphyria cutanea tarda | A | Accepted |
| E8020 | Unspecified porphyria | A | Accepted |
| E8021 | Acute intermittent (hepatic) porphyria | A | Accepted |
| E8029 | Other porphyria | A | Accepted |
| E803 | Defects of catalase and peroxidase | A | Accepted |
| E804 | Gilbert syndrome | A | Accepted |
| E805 | Crigler-Najjar syndrome | A | Accepted |
| E806 | Other disorders of bilirubin metabolism | A | Accepted |
| E807 | Disorder of bilirubin metabolism, unspecified | A | Accepted |
| E8300 | Disorder of copper metabolism, unspecified | A | Accepted |
| E8301 | Wilson's disease | A | Accepted |
| E8309 | Other disorders of copper metabolism | A | Accepted |
| E8310 | Disorder of iron metabolism, unspecified | A | Accepted |
| E83110 | Hereditary hemochromatosis | A | Accepted |
| E83111 | Hemochromatosis due to repeated red blood cell transfusions | A | Accepted |
| E83118 | Other hemochromatosis | A | Accepted |
| E83119 | Hemochromatosis, unspecified | A | Accepted |
| E8319 | Other disorders of iron metabolism | A | Accepted |
| E832 | Disorders of zinc metabolism | A | Accepted |
| E8330 | Disorder of phosphorus metabolism, unspecified | A | Accepted |
| E8331 | Familial hypophosphatemia | A | Accepted |
| E8332 | Hereditary vitamin D-dependent rickets (type 1) (type 2) | A | Accepted |
| E8339 | Other disorders of phosphorus metabolism | A | Accepted |
| E8340 | Disorders of magnesium metabolism, unspecified | A | Accepted |
| E8341 | Hypermagnesemia | A | Accepted |
| E8342 | Hypomagnesemia | A | Accepted |
| E8349 | Other disorders of magnesium metabolism | A | Accepted |
| E8350 | Unspecified disorder of calcium metabolism | A | Accepted |
| E8351 | Hypocalcemia | A | Accepted |
| E8352 | Hypercalcemia | A | Accepted |
| E8359 | Other disorders of calcium metabolism | A | Accepted |
| E8381 | Hungry bone syndrome | A | Accepted |
| E83820 | Gen arterial calcifcn of infancy with unsp genetic causality | A | Accepted |
| E83821 | ENPP1 deficiency causing gen arterial calcifcn of infancy | A | Accepted |
| E83822 | ENPP1 def cause autosom recess hypophosphate rickets type 2 | A | Accepted |
| E83823 | ABCC6 deficiency causing gen arterial calcifcn of infancy | A | Accepted |
| E83824 | ABCC6 deficiency causing pseudoxanthoma elasticum | A | Accepted |
| E83825 | CD73 deficiency causing arterial calcification | A | Accepted |
| E8389 | Other disorders of mineral metabolism | A | Accepted |
| E839 | Disorder of mineral metabolism, unspecified | None | Cannot group |
| E840 | Cystic fibrosis with pulmonary manifestations | I | Accepted |
| E8411 | Meconium ileus in cystic fibrosis | A | Accepted |
| E8419 | Cystic fibrosis with other intestinal manifestations | I | Accepted |
| E848 | Cystic fibrosis with other manifestations | I | Accepted |
| E849 | Cystic fibrosis, unspecified | I | Accepted |
| E850 | Non-neuropathic heredofamilial amyloidosis | I | Accepted |
| E851 | Neuropathic heredofamilial amyloidosis | I | Accepted |
| E852 | Heredofamilial amyloidosis, unspecified | I | Accepted |
| E853 | Secondary systemic amyloidosis | I | Accepted |
| E854 | Organ-limited amyloidosis | I | Accepted |
| E8581 | Light chain (AL) amyloidosis | I | Accepted |
| E8582 | Wild-type transthyretin-related (ATTR) amyloidosis | I | Accepted |
| E8589 | Other amyloidosis | I | Accepted |
| E859 | Amyloidosis, unspecified | I | Accepted |
| E860 | Dehydration | A | Accepted |
| E861 | Hypovolemia | A | Accepted |
| E869 | Volume depletion, unspecified | A | Accepted |
| E870 | Hyperosmolality and hypernatremia | A | Accepted |
| E871 | Hypo-osmolality and hyponatremia | A | Accepted |
| E8720 | Acidosis, unspecified | A | Accepted |
| E8721 | Acute metabolic acidosis | A | Accepted |
| E8722 | Chronic metabolic acidosis | A | Accepted |
| E8729 | Other acidosis | A | Accepted |
| E873 | Alkalosis | A | Accepted |
| E874 | Mixed disorder of acid-base balance | A | Accepted |
| E875 | Hyperkalemia | A | Accepted |
| E876 | Hypokalemia | A | Accepted |
| E8770 | Fluid overload, unspecified | A | Accepted |
| E8771 | Transfusion associated circulatory overload | A | Accepted |
| E8779 | Other fluid overload | A | Accepted |
| E878 | Oth disorders of electrolyte and fluid balance, NEC | A | Accepted |
| E8801 | Alpha-1-antitrypsin deficiency | A | Accepted |
| E8802 | Plasminogen deficiency | A | Accepted |
| E8809 | Oth disorders of plasma-protein metabolism, NEC | A | Accepted |
| E8810 | Lipodystrophy, unspecified | A | Accepted |
| E8811 | Partial lipodystrophy | A | Accepted |
| E8812 | Generalized lipodystrophy | A | Accepted |
| E8813 | Localized lipodystrophy | A | Accepted |
| E8814 | HIV-associated lipodystrophy | A | Accepted |
| E8819 | Other lipodystrophy, not elsewhere classified | A | Accepted |
| E882 | Lipomatosis, not elsewhere classified | A | Accepted |
| E883 | Tumor lysis syndrome | A | Accepted |
| E8840 | Mitochondrial metabolism disorder, unspecified | A | Accepted |
| E8841 | MELAS syndrome | A | Accepted |
| E8842 | MERRF syndrome | A | Accepted |
| E8843 | Disorders of mitochondrial tRNA synthetases | A | Accepted |
| E8849 | Other mitochondrial metabolism disorders | A | Accepted |
| E88810 | Metabolic syndrome | A | Accepted |
| E88811 | Insulin resistance syndrome, Type A | A | Accepted |
| E88818 | Other insulin resistance | A | Accepted |
| E88819 | Insulin resistance, unspecified | A | Accepted |
| E8882 | Obesity due to disruption of MC4R pathway | A | Accepted |
| E8889 | Other specified metabolic disorders | A | Accepted |
| E889 | Metabolic disorder, unspecified | None | Cannot group |
| E88A | Wasting disease (syndrome) due to underlying condition | None | Not accepted |
Source: CMS HH PPS Grouper Software v07.1.26, effective 2026-04-01. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.
The monthly home health regs digest
What CMS changed, what's due next, and what to do about it — one email a month, no fluff.